Serge Saxonov - Dec 23, 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Executive Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol: TXG
Transactions as of: Dec 23, 2024
Transactions value $: $14,400
Form type: 4
Date filed: 12/23/2024, 08:29 PM
Previous filing: Nov 25, 2024
Next filing: Feb 26, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$14.4K	+12K	+1.38%	$1.20	885K	Dec 23, 2024	Direct
holding	TXG	Class A Common Stock						27	Dec 23, 2024	See footnote	F1
holding	TXG	Class A Common Stock						870	Dec 23, 2024	See footnote	F2
holding	TXG	Class A Common Stock						213K	Dec 23, 2024	See footnote	F3
holding	TXG	Class A Common Stock						22.6K	Dec 23, 2024	See footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-12K	-15.1%	$0.00	67.5K	Dec 23, 2024	Class A Common Stock	12K	$1.20	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2	The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F3	The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4	The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F5	This option, originally for 300,000 shares, of which 232,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021.